Changing patterns of opioid agonist therapy prescribing in a network of specialised clinics providing care to people with opioid use disorder in <scp>Victoria</scp>, <scp>Australia</scp>, 2015 to 2023
We found substantial changes in OAT prescribing patterns in Victoria between 2015 and 2023, with shifts away from oral methadone and sublingual buprenorphine to LAIB. Alongside ongoing monitoring of prescribing patterns, future research should assess how LAIB impacts patient health and social outcomes.
Authors
- Margaret Elena Hellard (ORCID: https://orcid.org/0000-0002-5055-3266)
- M. David Curtis (ORCID: https://orcid.org/0000-0002-1814-0867)
- Paul Dietze (ORCID: https://orcid.org/0000-0001-7871-6234)
- Charles Henderson (ORCID: https://orcid.org/0000-0001-6905-8858)
- Jason Asselin (ORCID: https://orcid.org/0000-0003-0823-4816)
- Joshua Dawe (ORCID: https://orcid.org/0000-0002-3227-9849)
- Mark A Stoove (ORCID: https://orcid.org/0000-0003-2887-1409)
- Anna Lee Wilkinson (ORCID: https://orcid.org/0000-0002-4475-5224)
- Eric Makoni
Institutions
- Burnet Institute (AU)
- The University of Melbourne (AU)
- La Trobe University (AU)
- Curtin University (AU)
- Charles Darwin University (AU)
- University of Bristol (GB)
- National Association of People with HIV Australia (AU)
- Peter Doherty Institute (AU)
- Melbourne Health (AU)
- Alfred Health (AU)
- Monash University (AU)
Publication Details
- Journal
- Drug and Alcohol Review
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1111/dar.14049
- Citations
- 1
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.88
Funders
- Department of Health and Aged Care, Australian Government